Could a 3-Week radiation course replace 6 weeks for head and neck cancer?

NCT ID NCT07573956

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a standard 6-week radiation course after surgery to a shorter 3-week course for people with head and neck cancer. The goal is to see if the shorter schedule works just as well at preventing cancer from coming back. About 369 participants will be randomly assigned to one of the two radiation plans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
radiation therapy
What this could lead to
If successful, this could offer a shorter, more convenient radiation schedule (3 weeks instead of 6) for head and neck cancer patients after surgery, potentially with similar cancer control.
What could go wrong
This is an early-to-mid stage trial, so results are not yet proven. The shorter schedule may not control cancer as well or could cause different side effects. The study is also limited to patients with specific risk features.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dr. Aman Sharma, Associate Professor, Radiation Oncology, NCI, AIIMS

    RECRUITING

    Jhajjar, Haryana, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.